- Market Realist•31 minutes ago
Vertex Pharmaceuticals' revenues fell in 2013 and 2014 due to sales from Incivek. But with the successful launch of Kalydeco, it returned to growth.
- Market Realist•6 days ago
Through the acquisition of Raptor Pharmaceuticals, Horizon Pharma (HZNP) will gain access to Procysbi and Quinsair and expand in the orphan drug space.
Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||86.07 x 100|
|Ask||91.02 x 100|
|Day's Range||88.10 - 91.23|
|52wk Range||75.90 - 134.71|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-77.86|
|Avg Vol (3m)||1,336,995|
|Dividend & Yield||N/A (N/A)|